Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
International Journal of Immunopharmacology|January 4, 2001
Macrophage activation by antiviral acyclic nucleoside phosphonates in dependence on priming immune stimuliZ Zídek, D Franková, A HolýAntimicrobial Agents and Chemotherapy|November 16, 2001
Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) productionZ Zídek, D Franková, A HolýActa Virologica|May 1, 1992
Pretreatment of the host cell with 1-(S)-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) is sufficient for its antiviral effectB Otová, I Votruba, A HolýCasopis Lekaru Ceskych|November 8, 2008
[Acyclic nucleoside phosphonates as potential antineoplastic agents]I Votruba, B Otová, A HolýEuropean Journal of Pharmacology|July 23, 1997
Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide productionZ Zídek, A Holý, D FrankováInternational Journal of Immunopharmacology|June 24, 1998
Immunomodulatory properties of antiviral acyclic nucleotide analogues: cytokine stimulatory and nitric oxide costimulatory effectsZ Zídek, A Holý, D FrankováTeratology|December 1, 1981
Embryotoxicity of 9-(S)-(2,3-dihydroxypropyl)adenineR Jelínek, A Holý, I VotrubaMolecular and Biochemical Parasitology|July 14, 1998
Arrest of Trypanosoma brucei rhodesiense and T. brucei brucei in the S-phase of the cell cycle by (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine ((S)-HPMPA)R Kaminsky, B Nickel, A HolýAntimicrobial Agents and Chemotherapy|February 1, 1989
Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivoE De Clercq, A Holý, I RosenbergActa Virologica|May 1, 1983
Metabolism of the broad-spectrum antiviral agent, 9-(S)-(2,3-dihydroxypropyl) adenine, in different cell linesI Votruba, A Holý, E De ClercqPageof 12